ACHIEVE LIFE SCIENCES INC Share · US0044685008 · ACHV · A2QAR3 (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of ACHIEVE LIFE SCIENCES INC

No Price

01.05.2026 23:37

Current Prices from ACHIEVE LIFE SCIENCES INC

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	ACHV	USD	01.05.2026 23:37	4,43 USD	0,04 USD +0,91 %
IEX	ACHV	USD	01.05.2026 19:59	4,38 USD	-0,010 USD -0,23 %
Quotrix	ALSIRS08.DUSD	EUR	30.04.2026 12:39	3,50 EUR	-
Düsseldorf	ALSIRS08.DUSB	EUR	30.04.2026 06:11	3,46 EUR	-
Hamburg	ALSIRS08.HAMB	EUR	30.04.2026 06:07	3,54 EUR	-

Company Profile for ACHIEVE LIFE SCIENCES INC Share

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.